Role of the dopaminergic system in depression.

Department of Psychiatry, University of Pittsburgh School of Medicine, PA.
Biological Psychiatry (Impact Factor: 9.47). 08/1992; 32(1):1-17. DOI: 10.1016/0006-3223(92)90137-O
Source: PubMed

ABSTRACT A hypothesis implicating dopamine in depression was proposed over 15 years ago (Randrup et al 1975). The identification of multiple new subtypes of dopamine receptors and evolving views regarding the function of the dopamine systems in the brain require a reexamination of this hypothesis. Results from studies in depression, Parkinson's disease, and animal models of depression suggest a deficiency of dopamine in depression. Dopamine precursors, dopamine agonists, and dopamine reuptake inhibitors show therapeutic efficacy in depression. Electroconvulsive therapy (ECT) and standard pharmacological antidepressants enhance dopamine function. Studies using receptor-specific drugs in clinical trials and neuroimaging studies are needed to further clarify the role of dopamine in depression.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute pain induces depressed mood, and chronic pain is known to cause depression. Depression, meanwhile, can also adversely affect pain behaviors ranging from symptomology to treatment response. Pain and depression independently induce long-term plasticity in the central nervous system (CNS). Comorbid conditions, however, have distinct patterns of neural activation. We performed a review of the changes in neural circuitry and molecular signaling pathways that may underlie this complex relationship between pain and depression. We also discussed some of the current and future therapies that are based on this understanding of the CNS plasticity that occurs with pain and depression.
    Neural Plasticity 01/2015; 2015:504691. DOI:10.1155/2015/504691 · 3.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Depression is an important syndrome occuring frequently during the course of schizophrenia. In patients using atypical antipsychotics in the treatment of schizophrenia, depressive symptoms are expected at a lower rate. In this retrospective study, evaluation of depressive symptoms in patients who were monitored for one year with first-episode schizophrenia using atypical or conventional antipsychotic treatment was intended. Methods: The study was carried out by examining the records of 93 patients with first-episode schizophrenia. The data of the Brief Psychiatric Rating Scale, Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms, Hamilton Depression Rating Scale (HDRS) and the Calgary Depression Scale were used for evaluation. Classical antipsychotics (n=21), olanzapine (n=28), risperidone (n=25) or quetia-pine (n=19) were found to be used in the treatment of subjects. According to clinical status, the subjects were invited to the controls at intervals not longer than two months. The above scales were applied to subjects at each control to measure the depressive symptoms and to determine the relationship of those with clinical variables. Results: The classic antipsychotic group (57.1%) showed more significantly severe depressive symptoms (HDRS score >= 17) than the atypical antipsychotic group (31.9%). The rate of depression and depressive symptoms were similar among the subjects used atypical antipsychotic agents. Conclusion: Possibly depending on their mechanism of action and the effects on negative symptoms of patients with schizophrenia, the atypical antipsychotic drugs showed lower rate of depression compared to conventional antipsychotics.
    Anadolu Psikiyatri Dergisi 01/2014; 16(1):1. DOI:10.5455/apd.151212 · 0.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Depressive patients frequently report to perceive time as going by very slowly. Potential effects of depression on duration judgments have been investigated mostly by means of four different time perception tasks: verbal time estimation, time production, time reproduction, and duration discrimina-tion. Ratings of the subjective flow of time have also been obtained. Methods: By means of a classical random-effects meta-regression model and a robust variance estimation model, this meta-analysis aims at evaluating the inconsistent results from 16 previous studies on time perception in depression, representing data of 433 depressive patients and 485 healthy control subjects. Results: Depressive patients perceive time as going by less quickly relative to control subjects (g ¼0.66, p¼ 0.033). However, the analyses showed no significant effects of depression in the four time perception tasks. There was a trend towards inferior time discrimination performance in depression (g ¼ 0.38, p¼ 0.079). The meta-regression also showed no significant effects of interval duration. Thus, the lack of effects of depression on timing does not depend on interval duration. However, for time production, there was a tendency towards overproduction of short and underproduction of long durations in depressive patients compared to healthy controls. Limitations: Several aspects, such as influences of medication and the dopaminergic neurotransmitter system on time perception in depression, have not been investigated in sufficient detail yet and were therefore not addressed by this meta-analysis. Conclusions: Depression has medium effects on the subjective flow of time whereas duration judgments basically remain unaffected.
    Journal of Affective Disorders 01/2015; 175:359-372. DOI:10.1016/j.jad.2014.12.057 · 3.71 Impact Factor